Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Feb 01, 2015 1:28pm
291 Views
Post# 23386453

Generics co Ani Pharm SP goes from $6.00 to $55 in a yr

Generics co Ani Pharm SP goes from $6.00 to $55 in a yr

ANI Pharmaceuticals (NASDAQ:ANIP) has transformed itself over the last 18 months. The company has successfully completed a reverse merger in June 2013, and its share price has increased from $6 at the time of the reverse merger to over $50 in early 2015.

A brief overview of the events that have driven ANI's share price higher in the last 18 months

Let us look at what were the main drivers for ANI's rapid share price advance since June 2013 (you can also see how the developments affected ANI's share price in the chart below):

- BioSante and ANI Pharmaceuticals complete a reverse merger in June 2013.

- On December 26, 2013, the company announces the acquisition of 31 generic products from Teva (NYSE:TEVA) for $12.5 million in cash plus a percentage of future sales. The acquisition effectively expanded the company's addressable market by $860 million.

Bullboard Posts